The latest price target for SILO Pharma (NASDAQ:SILO) was reported by Laidlaw & Co. on August 28, 2023. The analyst firm set a price target for $10.00 expecting SILO to rise to within 12 months (a possible 890.20% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for SILO Pharma (NASDAQ:SILO) was provided by Laidlaw & Co., and SILO Pharma initiated their buy rating.

There is no last upgrade for SILO Pharma

There is no last downgrade for SILO Pharma.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SILO Pharma, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SILO Pharma was filed on August 28, 2023 so you should expect the next rating to be made available sometime around August 28, 2024.

While ratings are subjective and will change, the latest SILO Pharma (SILO) rating was a initiated with a price target of $0.00 to $10.00. The current price SILO Pharma (SILO) is trading at is $1.01, which is within the analyst’s predicted range.